Prescription Patterns of Medications for Alzheimer's Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study - Wikidata - wikimedia - TriplyDB

Prescription Patterns of Medications for Alzheimer's Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study

Prescription Patterns of Medications for Alzheimer's Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study

http://www.wikidata.org/entity/Q33736188

about

Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis.Diabetes mellitus and risk of early-onset Alzheimer's disease: a population-based case-control study.

P2860

Q33650097-7200B317-37AE-463D-83DA-0DB4656A945E Q38786495-FFDF12B9-5296-4231-8799-46E8F27EDE37

P2860

Prescription Patterns of Medications for Alzheimer's Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study

http://www.wikidata.org/entity/Q33736188

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Prescription Patterns of Medic ...... Pharmacy Claims Database Study

@ast

Prescription Patterns of Medic ...... Pharmacy Claims Database Study

@en

type

label

Prescription Patterns of Medic ...... Pharmacy Claims Database Study

@ast

Prescription Patterns of Medic ...... Pharmacy Claims Database Study

@en

prefLabel

Prescription Patterns of Medic ...... Pharmacy Claims Database Study

@ast

Prescription Patterns of Medic ...... Pharmacy Claims Database Study

@en

P1433

Q33736188-CAFE4A1D-6A4F-4C44-B2D4-FC7BB3F566EF

P1476

Q33736188-A02337A4-D1E7-4F74-94A7-BE02399E67CD

P2093

Q33736188-303F0C81-A484-40C4-99E5-7B8C5702122F

Q33736188-36B3738B-FCBC-4A5B-A44C-C9F5C67D691A

Q33736188-6BE981DC-5AE1-4B4A-A68E-AFDC1BB850A5

Q33736188-90AAFE1A-C4B5-4E9A-A08C-543FF7E3117E

Q33736188-94C5FFC3-D17A-42C4-9945-B8B106579276

Q33736188-B567DD85-E050-49CB-A9A7-F4199D912BB0

Q33736188-EED03EB4-4322-4142-A62F-9B1E22D720E7

P2860

Q33736188-0DC4B0A5-9A42-4259-BFA1-87647AB61941

Q33736188-1D4CC56A-8B03-4DF8-87D0-0910CFB4EC81

Q33736188-27B20D62-099B-4C1A-B765-3EC9FEB8DB3B

Q33736188-6DCD807D-6F7E-491B-AF9D-966B860B19B4

Q33736188-6DF3659A-A2B4-4ABC-BBC2-8384E66C7A69

Q33736188-6E92D327-2137-4545-BFDB-F2AC9CB03A67

Q33736188-889AFBED-404C-4517-AFB9-F927511AED75

Q33736188-C473C65C-6B74-4A4F-ADB6-AA740FD43BDB

Q33736188-CC843E95-20EB-4F68-9512-E189B441C45B

Q33736188-E1D58CDC-ADBB-4635-AA59-D492AB85D303

P2888

Q33736188-2A969243-BCF5-47E5-97C9-A22DBE581237

P304

Q33736188-F3F8DA2A-06C5-48F3-8409-C71313F408FD

P31

Q33736188-4BD81F8B-BD08-431D-ABCB-BC792D122B25

P356

Q33736188-9C77EB73-74D8-4729-8281-AB0FC2843248

P433

Q33736188-3B91C758-E762-4691-81C9-013679F1B67E

P478

Q33736188-99F0EB2D-08A9-4B9D-BEDE-240947E16606

P577

Q33736188-043C3D1B-6A08-4AF1-88C4-39A80196F358

P6179

Q33736188-6514286C-3B56-47FF-96DF-22ABDEE26E57

P698

Q33736188-75096059-8E59-4DD8-B69D-4EAB534A64F4

P921

Q33736188-5915E99E-A160-46BA-9FF3-A68AAE9D366A

P932

Q33736188-587CBD58-11CD-4240-A823-AC8C57BBFC9B

P356

S40120-016-0057-1

P1433

Neurology and therapy

P1476

Prescription Patterns of Medic ...... Pharmacy Claims Database Study

@en

P2093

Izumi Sato

http://www.w3.org/2001/XMLSchema#string

Kimiko Kadohara

http://www.w3.org/2001/XMLSchema#string

Koji Kawakami

http://www.w3.org/2001/XMLSchema#string

Masaru Arai

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Matsunaga

http://www.w3.org/2001/XMLSchema#string

Yosuke Fujii

http://www.w3.org/2001/XMLSchema#string

Yuko Doi

http://www.w3.org/2001/XMLSchema#string

P2860

Oseltamivir prescription and regulatory actions vis-à-vis abnormal behavior risk in Japan: drug utilization study using a nationwide pharmacy database

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practice.

Risk factors for medication nonadherence in older adults with cognitive impairment who live alone.

Trends in antidiabetic prescription patterns in Japan from 2005 to 2011.

A population-based study of dosing and persistence with anti-dementia medications.

Multicentre population-based dementia prevalence survey in Japan: a preliminary report.

Continuous treatment with antidementia drugs in Germany 2003-2013: a retrospective database analysis.

Trends in recognition and treatment of dementia in france analysis of the 2004 to 2010 database of the national health insurance plan.

Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings.

P2888

s40120-016-0057-1

P304

25-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40120-016-0057-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038766341

http://www.w3.org/2001/XMLSchema#string

P698

27896785

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5447550

http://www.w3.org/2001/XMLSchema#string